Patients with high-risk AML, that is, megakaryoblastic leukemia ... with two courses of consolidation chemotherapy consisting of cytarabine (3 g/m 2 per dose every 12 h on days 1, 2, 8 ...

Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 ...

Medindia neither buys nor sells drugs. Cytarabine (Cytarabine ) is a chemotherapy agent, prescribed for acute myeloid leukemia (AML) and non-Hodgkin lymphoma. Cytarabine (Cytarabine ) slows the ...

This early unblinding will involve 30 participants receiving the combination of annamycin and cytarabine ... gains approval for enrolment in trial of AML therapy in Ukraine" was originally ...

Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...

and engaged leading contract research organization (CRO); On track to begin dosing of Annamycin in combination with cytarabine for the treatment of R/R AML in Q1 2025 – Expected timelines for ...